Heart Failure Education Initiative

While there is no cure for HF, many people with this condition can live full, enjoyable lives and disease progression can be slowed. While people with early-stage HF often can manage their condition with lifestyle modifications and medications, more advanced therapies may be needed as the disease progresses. Yet, fewer than half of patients who may benefit from advanced HF specialty care ever receive it — a gap that particularly affects populations with limited access to health care resources

About 6.7 million American adults are living with HF, and prevalence is expected to reach more than 8 million by 2030. 

The American Heart Association, a global force for healthier lives for all, has launched a new $3 million initiative, supported by Abbott, that aligns with the rising need for advanced treatment pathways and education beyond traditional guideline-directed medical therapy. This effort will provide cardiovascular clinicians with tools to support a growing HF population, including information on care models that connect specialists and clinical teams to improve patient outcomes.